Amarin Corp Plc (AMRN)

[Pyrrhonian]

They're making purely factual, statistical statements. Note how the percentages are almost the same. Pretty consistent. --TGW

Unless the difference is significant, it cannot be deemed reliable. The only reliable difference in MACE between groups -- the only one -- was unstable angina.

That's how investors get themselves into trouble, by over-extending an interpretation of "trends."

Like:

The overall survival showed a trend toward longer survival with L-BLP25 plus the BSC vs. BSC alone [median: 17.4 vs. 13.0 months; adjusted hazard ratio (HR): 0.739, 95% CI: 0.509-1.073; P=0.112], with a post hoc subgroup analysis (n=65) suggesting a greater survival benefit in patients with stage IIIB locoregional disease. An updated analysis confirmed the survival benefit in this subgroup of patients (median: 30.6 months for L-BLP25 plus BSC vs. 13.3 months for BSC alone; adjusted HR: 0.548; 95% CI: 0.301-0.999).

Trends pop up for many different reasons, but aren't reliable, and so shouldn't be relied upon in forming a long thesis.

Jmo

GL